Cancer Center Clínica Universidad de Navarra (CCUN)
Centro clínico de la Universidad de Navarra
Thomas Jefferson University
Filadelfia, Estados UnidosPublicaciones en colaboración con investigadores/as de Thomas Jefferson University (11)
2022
-
Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study
Gynecologic Oncology, Vol. 166, Núm. 1, pp. 36-43
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Integrated Multiomics Reveals Glucose Use Reprogramming and Identifies a Novel Hexokinase in Alcoholic Hepatitis
Gastroenterology, Vol. 160, Núm. 5, pp. 1725-1740.e2
-
STATegra: Multi-Omics Data Integration – A Conceptual Scheme With a Bioinformatics Pipeline
Frontiers in Genetics, Vol. 12
2020
-
A Novel Mouse Model of Acute-on-Chronic Cholestatic Alcoholic Liver Disease: A Systems Biology Comparison With Human Alcoholic Hepatitis
Alcoholism: Clinical and Experimental Research, Vol. 44, Núm. 1, pp. 87-101
-
Hepatic lipocalin 2 promotes liver fibrosis and portal hypertension
Scientific Reports, Vol. 10, Núm. 1
-
Niraparib in Patients With Newly Diagnosed Advanced Ovarian Cancer
Obstetrical and Gynecological Survey
2019
-
Niraparib in patients with newly diagnosed advanced ovarian cancer
New England Journal of Medicine, Vol. 381, Núm. 25, pp. 2391-2402
2017
-
T Cell Migration from Inflamed Skin to Draining Lymph Nodes Requires Intralymphatic Crawling Supported by ICAM-1/LFA-1 Interactions
Cell Reports, Vol. 18, Núm. 4, pp. 857-865
2011
-
Defining the critical hurdles in cancer immunotherapy
Journal of Translational Medicine
-
Research reporting standards for radioembolization of hepatic malignancies
Journal of Vascular and Interventional Radiology, Vol. 22, Núm. 3, pp. 265-278